Healthtech Late Stage Investors & VC Firms
847 firms in this list, with a median first check of $1M. 197 of them lead rounds. Generated from verified public data and updated continuously.
LIFTT
TorinoPre-Seed–Late Stage
35 people
Advent International
BostonSeries A–Late Stage$1.1B
47 people
Amadeus Capital Partners
LondonPre-Seed–Late Stage$50K – $12.7M
34 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
42 people
W Capital Partners
New YorkGrowth–Late Stage
21 people
Illumina Ventures
Foster CityPre-Seed–Late Stage
40 people
Capricorn Venture Partners
LeuvenSeed–Late Stage$270K – $10.8M
30 people
Advent Life Sciences
LondonSeed–Late Stage
29 people
Endeavour Capital
PortlandGrowth–Late Stage$35M – $100M
29 people
KAYA
PraguePre-Seed–Late Stage$108K – $3.2M
15 people
b2venture
BerlinPre-Seed–Late Stage$270K – $5.4M
36 people
BIP Ventures
AtlantaPre-Seed–Late Stage
19 people
Eclipse Ventures
Palo AltoPre-Seed–Late Stage$200K – $5M
37 people
Icehouse Ventures
AucklandPre-Seed–Late Stage$120K – $2.4M
30 people
Oxeon Partners
New YorkSeed–Late Stage
52 people
LRVHealth
BostonSeed–Late Stage$500K – $1M
28 people
Brentwood Associates
Growth–Late Stage$50M – $200M
35 people
Supernova Invest
ParisPre-Seed–Late Stage
32 people
Atlas Venture
CambridgeSeed–Late Stage$500K – $1M
24 people
Clessidra Capital Credit
MilanGrowth–Late Stage
51 people
Korys
HalleSeries A–Late Stage$5.4M
32 people
iSelect Fund
St. LouisSeed–Late Stage$250K – $2M
13 people
Quadrant Private Equity Pty Ltd.
SydneyGrowth–Late Stage$46.2M – $99M
43 people
Investible Climate Tech Fund
SydneyPre-Seed–Late Stage$330K
20 people
Related lists
Healthtech Investors & VC Firms (3208)Late Stage Investors & VC Firms (2864)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Healthtech Growth Investors & VC Firms (1213)Late Stage Investors & VC Firms in United States (1101)Late Stage Investors & VC Firms in Global (857)
Data sourced from public filings and firms' own websites — see our methodology.

































.png)





















































